All Stories

  1. Lactic acid produced by optimal vaginal Lactobacillus spp. potently and specifically inactivates HIV-1 in vitro by targeting the viral RNA genome and reverse transcriptase

    Article • PLoS Pathogens, October 2025, PLOS

    Professor Gilda Tachedjian

  2. Lactic acid in vaginal fluid inactivates HIV-1

    Article • mSphere, July 2018, ASM Journals

    Professor Gilda Tachedjian

  3. Differential Evolution of Antiretroviral Restriction Factors in Pteropid Bats as Revealed by APOBEC3 Gene Complexity

    Article • Molecular Biology and Evolution, March 2018, Oxford University Press (OUP)

    Professor Gilda Tachedjian

  4. Editorial (Thematic Issue: Current and Emerging Drug Targets for Human Immunodeficiency Virus)

    Article • Current Topics in Medicinal Chemistry, December 2015, Bentham Science Publishers

    Professor Gilda Tachedjian

  5. Bats and Rodents Shape Mammalian Retroviral Phylogeny

    Article • Scientific Reports, November 2015, Springer Science + Business Media

    Professor Gilda Tachedjian

  6. Mechanisms of HIV transmission in Depo-Provera users

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2015, Wolters Kluwer Health

    Professor Gilda Tachedjian

  7. Bats and Reverse Transcribing RNA and DNA Viruses

    Article • June 2015, Wiley

    Professor Gilda Tachedjian

  8. HIV-1 Infection of T Cells and Macrophages Are Differentially Modulated by Virion-Associated Hck: A Nef-Dependent Phenomenon

    Article • Viruses, September 2013, MDPI AG

    Professor Gilda Tachedjian

  9. The seventh (and last?) International Microbicides Conference: from discovery to delivery

    Article • Sexual Health, May 2013, CSIRO Publishing

    Dr Bridget Gabrielle Haire, Professor Gilda Tachedjian

  10. Role of RNase H Activity in NRTI/NNRTI Drug Resistance

    Article • January 2013, Springer Science + Business Media

    Professor Gilda Tachedjian

  11. Identification of diverse full-length endogenous betaretroviruses in megabats and microbats

    Article • Retrovirology, January 2013, Springer Science + Business Media

    Professor Gilda Tachedjian

  12. Host-Pathogen Interactions of Retroviruses

    Article • Molecular Biology International, October 2012, Hindawi Publishing Corporation

    Dr Suryaram Gummuluru, Professor Gilda Tachedjian

  13. Discovery of Retroviral Homologs in Bats: Implications for the Origin of Mammalian Gammaretroviruses

    Article • Journal of Virology, February 2012, ASM Journals

    Professor Gilda Tachedjian

  14. N348I in HIV-1 reverse transcriptase decreases susceptibility to tenofovir and etravirine in combination with other resistance mutations

    Article • AIDS, January 2010, Wolters Kluwer Health

    Professor Gilda Tachedjian

  15. Impact of Residues in the Nonnucleoside Reverse Transcriptase Inhibitor Binding Pocket on HIV-1 Reverse Transcriptase Heterodimer Stability

    Article • Current HIV Research, March 2008, Bentham Science Publishers

    Professor Gilda Tachedjian

  16. Targeting Human Immunodeficiency Virus Type 1 Assembly, Maturation and Budding

    Article • Drug Target Insights, January 2007, SAGE Publications

    Professor Gilda Tachedjian

  17. Antiretroviral Compounds: Mechanisms Underlying Failure of HAART to Eradicate HIV-1

    Article • Current Medicinal Chemistry, July 2005, Bentham Science Publishers

    Professor Gilda Tachedjian

  18. The Packaging and Maturation of the HIV-1 Pol Proteins

    Article • Current HIV Research, January 2005, Bentham Science Publishers

    Professor Gilda Tachedjian

  19. Efavirenz enhances the proteolytic processing of an HIV-1 pol polyprotein precursor and reverse transcriptase homodimer formation

    Article • FEBS Letters, December 2004, Wiley

    Professor Gilda Tachedjian

  20. Virological significance, prevalence and genetic basis of hypersusceptibility to nonnucleoside reverse transcriptase inhibitors

    Article • Sexual Health, January 2004, CSIRO Publishing

    Professor Gilda Tachedjian

  21. In Vitro Effectiveness of a Combination of Zidovudine and Ansamycin Against Human Immunodeficiency Virus

    Article • The Journal of Infectious Diseases, October 1988, Oxford University Press (OUP)

    Professor Gilda Tachedjian